Related Experiment Video
Updated: Jul 2, 2026

07:05
A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
Published on: August 24, 2017
Biofeedback treatment for headache disorders: a comprehensive efficacy review
Yvonne Nestoriuc1, Alexandra Martin, Winfried Rief
1Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. ynestoriuc@partners.org
Applied Psychophysiology and Biofeedback
|August 30, 2008
Summary
Biofeedback therapy demonstrates significant effectiveness for both migraine and tension-type headaches, improving frequency, self-efficacy, and reducing medication use. These positive effects on headache management are sustained long-term.
Area of Science:
- Neurology
- Behavioral Medicine
- Psychophysiology
Background:
- Migraine and tension-type headaches are highly prevalent neurological conditions.
- Effective, non-pharmacological treatments are sought for headache management.
- Biofeedback offers a potential therapeutic avenue by training self-regulation of physiological processes.
Purpose of the Study:
- To critically review the evidence on biofeedback efficacy for migraine and tension-type headaches.
- To synthesize findings from meta-analyses and outcome studies.
- To determine the level of evidence and recommend future research directions.
Main Methods:
- Systematic screening of 150 outcome studies, including RCTs and quasi-experimental designs.
- Inclusion of 94 selected studies based on predefined criteria.
- Meta-analytic integration of data for migraine and tension-type headache patients separately.
Main Results:
- Medium-to-large effect sizes for biofeedback in adult migraine and tension-type headache patients.
- Sustained treatment effects over a 14-month follow-up period.
- Significant improvements in headache frequency, self-efficacy, anxiety, depression, and medication consumption.
- Electromyographic feedback showed specific benefits for tension-type headache over placebo and relaxation therapies.
Conclusions:
- Biofeedback is an efficacious treatment for both migraine (Level 4) and tension-type headache (Level 5).
- The therapy demonstrates sustained benefits and improves multiple outcome measures.
- Further research is recommended to refine biofeedback protocols and applications.
